Allergy Therapeutics plc has announced that it has recently issued 4,928,544 ordinary shares in satisfaction of the exercise of share options. The new shares rank pari passu with the company's existing shares. As of November 30, 2023, the company has a total of 4,763,874,771 ordinary shares in issue, with no shares held in treasury. Therefore, the total number of voting rights in the company is 4,763,874,771. Shareholders can use this figure as the denominator for calculating their interest in the company's share capital under the FCA's Disclosure Guidance and Transparency Rules.